Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory (French, HTML)

View metadata and access the original French HTML file: Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory.

Format

HTML

Access

file-only

Publisher-reported update

2023-11-01

Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated to reflect that an ultrasound is no longer required before the drug is prescribed. Mifegymiso is a combination product containing two drugs (mifepristone and misoprostol) that are taken in sequence for the medical termination of a pregnancy.

Access original file